Ireland
--:--IST
Latest
Clinical Trials in Turkey / NCT07444697
Recruiting Observational

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697 · tracked via the Priya Life Science Turkey tracker
Phase
Observational
Started
2026-01-15
Last updated
2026-03-03

Condition(s) studied

Erectile DisfunctionCoronary Artery Disease (CAD)Diabete MellitusAnxietyDepression and Quality of Life

Study summary

The goal of this observational study is to assess changes in patients' erectile function after percutaneous coronary intervention (PCI) using a standard IIEF (International Index of Erectile Function) questionnaire at 1, 3, and 6 months post-PCI. By doing this, we try to compare patients' responses to PCI after having a heart attack and stable angina to see the real effect of myocardial infarction on erectile function status in the long term by comparing it with a very similar group.

Eligibility

Sex
MALE
Min age
30 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria * Male patients aged 30-75 years * Undergoing successful percutaneous coronary intervention (PCI) for one of the following: * Acute myocardial infarction (Group 1) * Stable angina (Group 2) * Hemodynamically stable after the PCI procedure * Survival of the index hospitalization * Ability to provide written informed consent * Sexually active within the 3 months prior to enrollment * Willingness and ability to complete follow-up visits and questionnaires at: * Baseline (post-PCI recovery) * 3 months * 6 months Exclusion Criteria * Known malignancy (active or recently treated) * Neurological disorders affecting erectile function, including: * Spinal cord injury * Multiple sclerosis * Parkinson's disease * Uncontrolled diabetes mellitus (HbA1c \> 9%) * Presence of more than two chronic systemic diseases, such as: * Severe renal disease * Severe hepatic disease * Severe pulmonary disease * Polypharmacy, defined as chronic use of more than three daily medications * Absence of sexual activity or lack of a sexual partner * Refusal or inability to provide informed consent or complete study questionnaires * Severe psychiatric illness interfering with study participation * Endocrine disorders, including: * Untreated hypogonadism * Thyroid disease * Major post-PCI complications preventing participation, including: * Reinfarction * Stroke * Heart failure

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The Hospital of Kirikkale Univerity Faculty of Medicine Kirikkale Turkey (Türkiye) Recruiting

More Kırıkkale University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07444697 on ClinicalTrials.gov ↗ ← All trials in Turkey